What is CL? Understanding Colgate-Palmolive's Q4 2025 Earnings Report

Colgate-Palmolive (CL) is a multinational consumer products company specializing in oral care, personal care, and home care products. The company reported its fourth quarter 2025 results on January 30, 2026, with earnings coming in line with expectations while revenues showed growth momentum. For investors tracking CL stock, the latest earnings release offers important clues about the company’s financial trajectory and what might drive its near-term performance.

Understanding CL’s Q4 2025 Financial Picture

The consumer products leader reported quarterly earnings of $0.91 per share, which matches the year-ago quarter result—meaning flat earnings growth despite ongoing business challenges. However, revenues climbed to $5.1 billion, representing a 3.2% increase compared to the same period last year. This revenue growth signals that the company is successfully expanding its top line, even as profitability remains steady. The earnings report itself demonstrates CL’s resilience in a competitive consumer goods market, but the question for investors becomes whether these results genuinely reflect operational strength or simply meet a low bar of expectations.

The Earnings Prediction Tools: What Analysts Are Signaling

Professional analysts use sophisticated tools to predict whether a company will beat or miss consensus estimates. The Zacks approach combines the “Most Accurate Estimate”—which incorporates the latest analyst revisions—with the broader consensus to generate what’s called an Earnings ESP (Expected Surprise Prediction). This metric theoretically indicates whether actual earnings will deviate from what the street expects. For CL, the consensus EPS estimate for the quarter had been revised 0.35% lower over the preceding 30 days, reflecting a collective reassessment by covering analysts.

The predictive model shows particular strength when a positive Earnings ESP combines with strong analyst ratings (Zacks Rank #1, #2, or #3). Research demonstrates that such combinations predict earnings beats roughly 70% of the time. However, for CL, the situation appears less favorable.

Why CL May Not Beat Expectations This Time

Here’s the critical finding: the Most Accurate Estimate for CL is lower than the Zacks Consensus Estimate, suggesting that recent analyst sentiment has turned somewhat bearish on the company’s near-term prospects. This mismatch generated an Earnings ESP of negative 0.04%. Meanwhile, CL carries a Zacks Rank of #4, which falls in the “Sell” category. This combination—negative ESP paired with a lower ranking—makes it statistically difficult to confidently predict that CL will outperform consensus expectations going forward.

Looking at historical precedent provides some encouragement, however. Over the past four consecutive quarters, CL has beaten consensus EPS estimates four times. In the most recent prior quarter, the company delivered $0.91 per share against expectations of $0.89, producing a positive surprise of 2.25%. This track record suggests the company has shown a pattern of matching or exceeding targets, even if current forward-looking indicators suggest caution.

What Investors Should Do

Management’s commentary during the earnings call will prove more decisive than the numbers themselves regarding whether CL stock rallies or retreats. Executives discussing business conditions and outlining future guidance carry significant weight in shaping investor sentiment and future earnings expectations. Simply beating or missing estimates by a penny doesn’t automatically dictate stock movement—many companies gain despite earnings disappointments if they offer compelling forward guidance, while others lose ground even after beating expectations due to other concerning factors.

For CL investors and those considering the stock, the prudent approach involves checking both the Earnings ESP metric and Zacks Rank ahead of major earnings catalysts. While CL doesn’t present a compelling earnings-beat candidate based on current forward indicators, investors shouldn’t dismiss the stock solely on this metric. Additional factors—dividend sustainability, competitive positioning, emerging market growth, and management execution—deserve equal consideration when making investment decisions about this consumer staples heavyweight.

The bottom line: CL’s latest results demonstrate a stable business, but near-term stock appreciation may depend more on management guidance and market sentiment than on another modest earnings beat.